Statements about S.2543: Prescription Drug Pricing Reduction Act of 2019

Nine members of Congress have made 11 statements about this bill.

Date	Member	Party	State / District	Title
May 26, 2020	Rodney Davis	R	IL-13	Davis Applauds Capping Cost of Insulin for Seniors
Dec. 11, 2019	Kevin Brady	R	TX-8	Brady, Walden, Foxx, Collins Push Bipartisan Plan to Lower Drug Costs
Dec. 11, 2019	Rodney Davis	R	IL-13	CBO Finds H.R. 3 Will Lead to Fewer New Prescription Drugs
Feb. 13, 2020	Roger Marshall	R	KS	Marshall Introduces Bipartisan Legislation to Improve Access to Groundbreaking Therapies
Feb. 13, 2020	David Schweikert	R	AZ-1	Congressman Schweikert Joins Bipartisan Bill to Improve Access to Gene Therapies
Feb. 13, 2020	Kurt Schrader	D	OR-5	Rep. Schrader Introduces Bipartisan Bill to Improve Access to Gene Therapies
Dec. 13, 2019	Lee Zeldin	R	NY-1	Rep. Zeldin Opposes House Dems Playing Partisan Politics with Prescription Drug Prices
Dec. 12, 2019	Richard Hudson	R	NC-9	Hudson Urges Bipartisanship to Lower Drug Prices
Oct. 11, 2019	Charles E. Grassley	R	IA	Grassley Statement on House Prescription Drug Bill CBO Score
Sept. 26, 2019	Charles E. Grassley	R	IA	Grassley, Wyden Release Legislative Text of Finance Committee-Passed Prescription Drug Pricing Reduction Act